Table 3.
Composite endpoint | All-cause mortality | Readmission due to HF | ||||
---|---|---|---|---|---|---|
HR (95% CI) | p | HR (95% CI) | p | HR (95% CI) | p | |
PAPP-A | ||||||
Univariable | 1.25 (1.09–1.42) | 0.001 | 1.30 (1.12–1.51) | 0.001 | 1.08 (0.85–1.38) | 0.525 |
Adjusted | 1.13 (0.94–1.35) | 0.185 | 1.10 (0.90–1.35) | 0.340 | 0.94 (0.65–1.35) | 0.729 |
Stanniocalcin-2 | ||||||
Univariable | 2.90 (1.81–4.64) | < 0.001 | 2.52 (1.47–4.29) | 0.001 | 5.37 (2.35–12.26) | < 0.001 |
Adjusted | 2.06 (1.13–3.75) | 0.018 | 2.23 (1.16–4.29) | 0.017 | 3.42 (1.22–9.60) | 0.020 |
IGFBP-4 | ||||||
Univariable | 3.29 (2.47–4.39) | < 0.001 | 3.18 (2.30–4.39) | < 0.001 | 2.69 (1.83–3.97) | < 0.001 |
Adjusted | 1.73 (1.14–2.64) | 0.010 | 1.44 (0.85–2.44) | 0.170 | 0.82 (0.42–1.60) | 0.562 |
Hs-TnT | ||||||
Univariable | 1.48 (1.32–1.65) | < 0.001 | 1.44 (1.27–1.63) | < 0.001 | 1.64 (1.36–1.98) | < 0.001 |
Adjusted | 1.07 (0.91–1.25) | 0.424 | 1.04 (0.87–1.25) | 0.665 | 1.00 (0.81–1.26) | 0.959 |
NT-ProBNP | ||||||
Univariable | 1.69 (1.54–1.84) | < 0.001 | 1.66 (1.50–1.84) | < 0.001 | 1.68 (1.43–1.97) | < 0.001 |
Adjusted | 1.21 (1.07–1.37) | 0.002 | 1.18 (1.02–1.36) | 0.028 | 1.24 (0.92–1.68) | 0.157 |
All HRs (95% CIs) are reported per 1-SD increment of natural log-transformed plasma levels
hs-TnT high-sensitivity troponin T, PAPP-A pregnancy-associated plasma protein-A, IGFBP-4 insulin-like growth factor binding protein-4